Profil
Karen B.
Chapman is the founder of Origen Therapeutics, Inc. She worked as the Vice President-Research at OncoCyte Corp.
from 2011 to 2017.
Chapman holds a graduate degree from Cornell University and a doctorate degree from The Johns Hopkins University School of Medicine, which she received in 1991.
Ehemalige bekannte Positionen von Karen B. Chapman
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOCYTE CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 22.03.2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Gründer | - |
Ausbildung von Karen B. Chapman
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Cornell University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Health Technology |
